TrialAnnals of internal medicine2017

Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Women: A Phase 2 Randomized Trial.

Roy M Gulick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.